Close
Achema middle east
swop processing & packaging

Drug Research

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option...

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select pre-phase 2...

US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis

The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple sclerosis...

Gilead and Novo Nordisk Expand NASH Clinical Collaboration

Gilead Sciences, Inc. and Novo Nordisk A/S announced that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). The companies will conduct a Phase...

Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy

Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of...

Insilicos Chemistry42 AI system integrated into UCBs drug discovery...

Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42â„¢ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico...

PsiVac and Lonza Enter a Strategic Agreement for the...

PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and...

Moderna Announces Supply Agreement to Provide 13 Million Doses...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply agreement with the Government of The Philippines for 13 million...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »